What Your Doctor May Not Tell You about Fibromyalgia: The Revolutionary Treatment That Can Reverse the Disease, Revised and Updated (4th Ed., 2019)
By R Paul St Amand, Claudia Craig Marek
Series: What Your Doctor May Not Tell You About
Language: English
Category: Ebook - Self-Help
Categories: Health/Fitness/Diet, Medicine/Psychology, Self-Help
Uploader: anoukaimee
Uploaded At: 2026-02-04 07:26:20
Published by Hachette, 2019. 3.6/321 GR, 4.5/911 Amazon. Developed the alt-health "guaifenesin protocol" in the 1990s.
Description
Tufts-educated physician who has proponed a [perhaps dubious] theory that 1) fibromyalgia is genetic; 2) the OTC cold medicine guaifenesin is "very effective" in treating it; and 3) a systemic inability to generate "sufficient energy" explains the illness. Snake oil? You decide!
BLURB ON AMAZON:
From an endocrinologist, a "groundbreaking" new protocol for reversing the devastating effects of fibromyalgia.
In this updated edition, Dr. St. Amand presents his latest findings on guaifenesin—a safe, affordable, and increasingly accessible medication that has shown remarkable success in treating fibromyalgia.
This revised edition also includes:
- Expanded insights into the current understanding and treatment of fibromyalgia
- Updated disease protocols and treatment strategies
- In-depth discussion on pharmaceutical options
With more patient anecdotes and a deeper exploration of symptoms, treatments, and outcomes, this book provides essential information for anyone affected by FMS.
REVIEWS
"I have seen the magic of guaifenesin and the program in What Your Doctor May Not Tell You About Fibromyalgia work." -Devin Starlanyl, author of The Fibromyalgia Advocate
"Groundbreaking... Dr. St. Amand's research will permit fibromyalgia to become merely a memory." -Dr. John Willems, MD, head, division of obstetrics and gynecology, Scripps Clinic
ABOUT THE AUTHORS
Dr. St. Amand discovered guaifenesin's use as a treatment for fibromyalgia, and his work is often cited. He is an Assistant Clinical Professor of Medicine and is on the teaching staff at UCLA Harbor General Hospital. He has been in practice for over 50 years.
Claudia Craig Marek was tutored, trained, and taught by Dr. St. Amand and has worked with him to discover more about the disease for many years.
403 pages (print edition)
NOTE ON SCIENTIFIC SCRUTINY, from Wikipedia:
"A 2017 multicenter, placebo-controlled, repeat-dose, parallel study of 77 randomly assigned adults, results suggested the potential for OTC dose of oral guaifenesin 1200 mg BID to provide symptomatic relief of upper back musculoskeletal pain and spasm.
Results of the only reported randomized clinical trial in 1996 found that guaifenesin had no significant effects on pain, other symptoms, or laboratory measures (serum and urinary levels of uric acid and phosphate) over 12 months in a sample of people diagnosed with fibromyalgia syndrome. The lead author of the study has suggested a number of reasons why some patients may have previously reported benefits on this protocol, concluding "St. Amand has unknowingly used guaifenesin as a powerful focus in a program of cognitive behavioral therapy, in which his empathy, enthusiasm and charisma were the real instruments in effecting a beneficial change."
St. Amand, who participated as a "Study Advisor" to this clinical trial, has stated that the study did not control for salicylate use, and therefore did not study the protocol as a whole. He has recommended a follow-up study be conducted which controls for all elements of the protocol. The lead author of the study counters that none of the subjects exhibited any signs of salicylate use."